We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 1.52% | 3.35 | 3.30 | 3.40 | 3.35 | 3.30 | 3.30 | 164,059 | 15:18:31 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.28 | 3.02M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/3/2024 17:50 | Booooom rns time.Why isn't Suzy being asked to vacate? | neotheone | |
04/3/2024 17:29 | 4p soon to be no P. | neotheone | |
04/3/2024 17:28 | lol porky!Suzy is that good at raising stuff James Cameron is eyeing her up for his next staring role in his follow up to the titanic movie.It's called raise the titanic, boom boom! | neotheone | |
04/3/2024 16:37 | Well here we are at 4p . Was laughed at by 412 some 6 months ago. Hope he is ok. | francoismyname | |
04/3/2024 08:45 | Did I say that 201 didn't need reformulating or patenting? No. I said the IP expires as in the current patent in 2027, so of course it needs reformulating or patenting for new Indication. Peepy said it has already expired, that is WRONG. He also said 301 is dead, WRONG. He's gaslighting and making it up as he gos along hoping no one will notice. Its basic stuff.., | ronpharma | |
04/3/2024 08:00 | My exact words to Adam and his exact reply so it can't be taken out of context.MeDo you feel optimistic about 201 as a drug considering it is 10 -15 years old now? AdamIt needs re-patenting and/or re-formulating. That could've been done now, two years later, whilst waiting for TX, so yes - but not as it is. | neotheone | |
04/3/2024 07:50 | He said it could potentially have been done in the last two years but he said 201 needs working on as is it currently stands.This in my opinion is one of the reasons TRX haven't yet completed the LOI and why other bigger companies where not interested in 201, because it needed a lot of work.If other big companies where interested and 201 was a winner then we wouldn't be sat here twiddling our thumbs waiting for TRX would we? | neotheone | |
04/3/2024 07:46 | Don’t believe me email him yourself and ask. | neotheone | |
04/3/2024 07:46 | Sorry Ron but your wrong!Spoke to Adam about this recently and he saidIt needs re-patenting and/or re-formulating.201 that is. | neotheone | |
04/3/2024 07:40 | That's not true.. 201 expires in 2027 (first one), as it is currently patented. 301 is being reformulated. So far from dead. Happy for counter arguments, but your post is factually incorrect. | ronpharma | |
02/3/2024 14:23 | @RonPharma 301 is a write off same as 201 IMO its connected/ outdated and superseded The IPR rights also expired on 201 so absolutely no hope now, just market hasn't caught on yet. Once its confirmed it will write the mcap down to about £2m tops - 1.7p to 2p share price IMO. Agree CLX is the only asset with value left but i put that at least 18mths if not longer for positioning. Doesn't matter if I'm right or you are we are both on the same page of a raise later this year. Personally i wont be supporting ANY raise at ANY level whilst this BOD remains in Situ. But i would consider a raise with a new board and a refocus on business priorities going forwards. For now, it remains totally uninvestable as it stands. | porky9 | |
02/3/2024 13:50 | Plus, 301. Don't know where that is, but likely at the same stage. New drug again when that is announced... | ronpharma | |
02/3/2024 13:49 | nope. But I didn't buy on 201. Bought for CLX, as it's gonna be a blockbuster and will be sold in about 13 months by my reckoning for a 400mil milestone deal. They needed a few hundred grand to go and demonstrate safety. Following board changes that's what's needed and that's why I'm in. They'll only have to raise 10 months max end of year to keep the lights on till that happens. Unless 401 pays the first tranche, which it might | ronpharma | |
02/3/2024 09:17 | @RonPharma You still confident that THX are going to execute that old LOI from 2021? By now even you must be thinking you were sold a pup? | porky9 | |
02/3/2024 09:09 | @JasonPugh No need to disrespect another poster with a different view to your own. You were out of order. For someone neurodivergent you of all people should live by the mantra that kindness counts. I’m no expert on the Matrix but there are clearly still a number of posters stuck in wonderland taking those red pills that Suzy is dishing out. The email reply you posted was just a set of canned answers. If talk and zero delivery impresses you then it might be worth you suggesting at the AGM they install a shareholder AI chat bot on the Valirx website that keeps rewording the same reply in different ways. It would certainly be cheaper than Shareholders paying Suzy a £180k package to do the same. | porky9 | |
01/3/2024 18:24 | Do you still like Orchard Rainmaker ? | nico115 | |
01/3/2024 17:46 | Martin gouldstone. Will he buy any shares in valirx? | jasonpugh | |
01/3/2024 08:45 | Hi Mr Anderson, My conspiracy question is that apparently neotheone had to go to hospital to get himself surgically removed from peepys backside. Is that true? | ronpharma | |
29/2/2024 22:31 | Welcome to conspiracy corner I am your host Mr Thomas Anderson. | neotheone | |
29/2/2024 22:27 | But wait mr porky this must be part of Suzy's grand conspiracy plan to take over the ip and then the world!I've heard rumours she is having secret meetings with vlad to learn his skills in regards to holding on to a position of power for an excessively long period of time. | neotheone | |
29/2/2024 16:18 | New NED with labs experience... more for labs... yawn. Suzy sings: Because you know I'm all about the labs 'Bout the labs, no revenue I'm all about the labs, 'bout the labs, nothing other, I'm all about the labs 'bout the labs, no revenue I'm all about the labs, 'bout that labs (labs, labs, labs) | porky9 | |
29/2/2024 12:53 | 🤦a | jasonpugh |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions